Platelet function in mitochondriopathy with stroke and stroke-like episodes

Summary Stroke and stroke-like episodes are frequent complications in mitochondriopathy, particulary in MELAS syndrome (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes) which is a disorder of the mitochondrial oxidative metabolism in diverse cell types. To clarify a possible pathological aspect of stroke in these patients, we investigated platelet function before and after physical exercise. Ten patients with mitochondriopathy and stroke and ten healthy sex and age matched controls were investigated in an analyst blinded, prospective cross-sectional trial. Exercise decreased intraplatelet adenosine triphosphate (ATP) concentrations by -22% from baseline in patients with mitochondriopathy (p<0.01 between groups) while exercise increased ATP-levels by 28% healthy controls (p=0.01 vs baseline). Thrombin receptor activating peptide (TRAP) stimulated P-selectin expression increased up to 50% (p<0.05) in healthy subjects following exercise compared to 39% (p>0.05) in patients with mitochondriopathy. Exercise trendwise decreased platelet plug formation under shear stress by 24% in patients as measured by the platelet function analyzer PFA-100®. Tromboelastography showed firm thrombus formation and delayed lysis in patients following exercise. In conclusion, this trial has shown that ATP depletion during and after exercise probably accounts for a defective oxidative metabolism in platelets of patients with mitochondriopathy and stroke. This might induce decreased platelet function in these patients but fails to explain the increased stroke rate. Therefore other mechanisms seem to be etiologically involved in the pathogenesis of stroke in patients with mitochondriopathy.

[1]  B. Jilma,et al.  Regulation of protease-activated receptor 1 (PAR1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humans , 2003, Thrombosis and Haemostasis.

[2]  B. Jilma.  Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. , 2001, The Journal of laboratory and clinical medicine.

[3]  R. Storey.  The P2Y 12 receptor as a therapeutic target in cardiovascular disease , 2001, Platelets.

[4]  H. Eichler,et al.  Paroxetine decreases platelet serotonin storage and platelet function in human beings , 2000, Clinical pharmacology and therapeutics.

[5]  B. Jilma,et al.  Monitoring of Aspirin (ASA) Pharmacodynamics with the Platelet Function Analyzer PFA-100® , 2000, Thrombosis and Haemostasis.

[6]  K. Majamaa,et al.  Increased activities of antioxidant enzymes and decreased ATP concentration in cultured myoblasts with the 3243A-->G mutation in mitochondrial DNA. , 2000, Biochimica et biophysica acta.

[7]  Eleni Tzima, John H. Walker.  Platelet annexin V: the ins and outs , 2000, Platelets.

[8]  M.C.D. Dalby, S.J. Davidson, J.F. Burman, S.W. Davies.  Diurnal variation in platelet aggregation with the PFA–100 platelet function analyser , 2000 .

[9]  J. Michiels,et al.  Aspirin and Platelet-Lowering Agents for the Prevention of Vascular Complications in Essential Thrombocythemia , 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[10]  P. Hjemdahl,et al.  Evidence for prothrombotic effects of exercise and limited protection by aspirin. , 1999, Circulation.

[11]  J. Christodoulou,et al.  Flow Cytometric Evaluation of Defects of the Mitochondrial Respiratory Chain , 1999, Journal of child neurology.

[12]  H. Eichler,et al.  Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans , 1999, Transfusion.

[13]  H. Heimpel,et al.  Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count , 1999, Journal of internal medicine.

[14]  C. Whitten,et al.  Assessment of changes in coagulation in parturients with preeclampsia using thromboelastography. , 1999, Anesthesiology.

[15]  K. Abe,et al.  Effect of coenzyme Q10 in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): Evaluation by noninvasive tissue oximetry , 1999, Journal of the Neurological Sciences.

[16]  P. Sheard,et al.  Decreased ATP synthesis is phenotypically expressed during increased energy demand in fibroblasts containing mitochondrial tRNA mutations. , 1999, European journal of biochemistry.

[17]  K. Majamaa,et al.  Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. , 1998, American journal of human genetics.

[18]  K. Krejcy,et al.  Effects of exercise on circulating vascular adhesion molecules in healthy men. , 1997, Immunobiology.

[19]  K. Majamaa,et al.  The common MELAS mutation A3243G in mitochondrial DNA among young patients with an occipital brain infarct , 1997, Neurology.

[20]  W. O’Neill,et al.  Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. , 1997, The Journal of laboratory and clinical medicine.

[21]  K. Clemetson,et al.  Platelet Adhesion and Aggregation Receptors , 1997 .

[22]  E. Stopa,et al.  Adult-onset MELAS. Evidence for involvement of neurons as well as cerebral vasculature in strokelike episodes. , 1996, Stroke.

[23]  A. Paetau,et al.  Laminar cortical necrosis in MELAS syndrome: MR and neuropathological observations. , 1996, Neuropediatrics.

[24]  H. Eichler,et al.  Effects of desmopressin on circulating P‐selectin , 1996, British journal of haematology.

[25]  J. Garcìa,et al.  Strokes in childhood. , 1995, Seminars in pediatric neurology.

[26]  Y. Raz,et al.  MELAS syndrome: peripheral neuropathy and cytochrome C-oxidase deficiency: a case report and review of the literature. , 1995, Israel journal of medical sciences.

[27]  N. Chu,et al.  Mitochondrial encephalomyopathies: CT and MRI findings and correlations with clinical features. , 1995, European neurology.

[28]  T. Hsiue,et al.  Different Effects of Strenuous Exercise and Moderate Exercise on Platelet Function in Men , 1994, Circulation.

[29]  H. Pollard,et al.  Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. , 1994, Biochimica et biophysica acta.

[30]  J. Cooper,et al.  Platelet mitochondrial function in Leber's hereditary optic neuropathy , 1994, Journal of the Neurological Sciences.

[31]  M. Selak.  Neutrophil-platelet interactions in inflammation. , 1994, Receptor.

[32]  J. Erikssen,et al.  Blood Platelet Count and Function Are Related to Total and Cardiovascular Death in Apparently Healthy Men , 1991, Circulation.

[33]  Y. Horiguchi,et al.  Purpuric Cutaneous Manifestations in Mitochondrial Encephalomyopathy , 1991, The Journal of dermatology.

[34]  F. Gabreëls,et al.  MELAS syndrome. Report of two patients, and comparison with data of 24 patients derived from the literature. , 1991, Neuropediatrics.

[35]  R. Sakuta,et al.  Vascular involvement in mitochondrial myopathy , 1989, Annals of neurology.

[36]  M. Tomasiak.  Importance of the malate-aspartate shuttle for the reoxidation of glycolytically produced NADH and for cell aggregation in porcine blood platelets. , 1987, Acta Biochimica Polonica.

[37]  W. Kuis,et al.  The Wiskott‐Aldrich syndrome: studies on a possible defect in mitochondrial ATP resynthesis in platelets , 1982, British journal of haematology.